Tourette's syndrome: [I-123]β-CIT SPECT correlates of vocal tic severity

Neurology

Volumn 51, Issue 4, 1998, Pages 1069-1074

  Heinz, A ^a   Knable, M B ^b   Wolf, S S ^a   Jones, D W ^a   Gorey, J G ^a   Hyde, T M ^a   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b Stanley Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; IODINE 123;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; MESENCEPHALON; NEUROTRANSMISSION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALAMUS; TIC;

EID: 0031709360     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.4.1069     Document Type: Article

References (39)

1. Hyde TM, Weinberger DR. Tourette's syndrome. A model neuropsychiatric disorder. JAMA 1995;273:498-501.
2. Swedo SE, Leonard HL. Childhood movement disorders and obsessive compulsive disorder. J Clin Psychiatry 1994; 55(suppl):32-37.
3. Cummings JL. Frontal-subcortical circuits and motor behavior. Arch Neurol 1993;50:873-880.
4. Baxter LR, Phleps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral glucose metabolic rates in obsessivecompulsive disorder. Arch Gen Psychiatry 1987;44:211-218.
5. Baxter LR, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 9:681-689.
6. Hyde TM, Stacey ME, Coppola R, Handel SF, Rickler KC, Weinberger DR. Cerebral morphometric abnormalities in Tourette's syndrome: a quantitative MRI study of monozygotic twins. Neurology 1995;45:1176-1182.
7. Cohen DJ, Shaywitz BA, Caparulo BK, Young JG, Bowers MB. Chronic multiple tics of Gilles de la Tourette's syndrome: CSF acid monoamine metabolites after probenecid administration. Arch Gen Psychiatry 1978;35:245-250.
8. Singer HS, Butler IJ, Tune LE, Seifert WE, Coyle JT. Dopaminergic dysfunction in Tourette syndrome. Ann Neurol 1979;12: 361-366.
9. Malison RT, McDougle CJ, van Dyck CH, et al. [123I]β-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiatry 1995;152:1359-1361.
10. Wolf SS, Jones DW, Knable MB, et al. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 1996;273:1225-1227.
11. Frankenburg FR, Kando JC. Sertraline treatment of attention deficit hyperactivity disorder and Tourette's syndrome. J Clin Psychopharmacol 1994;14:359-360.
12. Eapen V, Trimble MR, Robertson MM. The use of fluoxetine in Gilles de la Tourette syndrome and obsessive compulsive behaviours: preliminary clinical experience. Prog Neuropsychopharmacol Biol Psychiatry 1996;20:737-743.
13. Hauser RA, Zesiewicz TA. Sertraline-induced exacerbation of tics in Tourette's syndrome. Mov Disord 1995;10:682-683.
14. McDougle CJ, Goodman WK, Price LH. Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J Clin Psychiatry 1994;55(suppl):24-31.
15. Goetz CG. Clonidine and clonazepam in Tourette syndrome. In: Chase TN, Friedhoff AJ, Cohen DJ, eds. Advances in neurology, vol. 58. New York: Raven Press, 1992:245-251.
16. Farde L, Halldin C, Mueller L, Suhara T, Karlsson P, Hall H. PET study of [C-11] β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 1994;16:93-103.
17. Laruelle M, Baldwin RM, Malison RT, et al. SPECT imaging of dopamine and serotonin transporters with [123-I]β-CIT: pharmacological characterization of brain uptake in non-human primates. Synapse 1993;13:295-309.
18. The Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. Arch Neurol 1993;50: 1013-1016.
19. Leckman J, Riddle M, Hardin M, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Psychiatry 1989;28:566-573.
20. Kurlan R, Riddle M, Como P. Tourette Syndrome Association Unified Tic Rating Scale. Version 2.0. New York: Tourette Syndrome Association, 1990.
21. Baldwin RM, Zea-Ponce Y, Zoghbi SS, et al. Evaluation of the monoamine uptake site ligand [123-I]methyl 3β-(iodophenyl)-tropane-2β-carboxylate ([123-I]β-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI. Nucl Med Biol 1993;5:597-606.
22. Laruelle M, Wallace E, Seibyl JP, et al. Graphical, kinetic, and equilibrium analyses of in vivo [123-I]β-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 1994;14:982-994.
23. Lakke JPWF, Wilmink JT. A case of Gilles de la Tourette's syndrome with midbrain involvement. J Neurol Neurosurg Psychiatry 1985;48:1293-1296.
24. Sandyk R. A case of Tourette's syndrome with midbrain involvement. Int J Neurosci 1988;43:171-175.
25. Devinsky O. Neuroanatomy of Gilles de la Tourette's syndrome. Possible midbrain involvement. Arch Neurol 1983;40: 508-514.
26. Richardson EP. Neuropathological studies of Tourette syndrome. In: Friedhoff AJ, Chase TN, eds. Gilles de la Tourette syndrome. New York: Raven Press, 1982:83-87.
27. Wirtshafter D, Stratford TR, Asin KE. Evidence that serotonergic projections to the substantia nigra in the rat arise in the dorsal, but not the median, raphe nucleus. Neurosci Lett 1987;77:261-266.
28. Corvaja N, Doucet G, Bolam JP. Ultrastructure and synaptic targets of the raphe-nigral projection in the rat. Neuroscience 1993;55:417-427.
29. Sur C, Betz H, Schloss P. Immunochemical detection of the serotonin transporter in rat brain. Neuroscience 1996;73:217-231.
30. Brodie MS, Bunney EB. Serotonin potentiates dopamine inhibition of ventral tegmental area neurons in vitro. J Neurophysiol 1996;76:2077-2082.
31. Dewey SL, Smith GS, Logan J, et al. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J Neurosci 1995;15: 821-829.
32. Kelland MD, Freeman AS, Rubin J, Chiodo LA. Ascending afferent regulation of rat midbrain dopamine neurons. Brain Res Bull 1993;31:539-546.
33. Trent F, Tepper JM. Dorsal raphe stimulation modifies striatal-evoked antidromic invasion of nigral dopaminergic neurons in vivo. Exp Brain Res 1993;84:620-630.
34. McCormick DA. Neurotransmitter actions in the thalamus and cerebral cortex. J Clin Neurophysiol 1992;9:212-223.
35. Storozhuk VM, Sachenko W, Kruchenko JA. Dependence of sensorimotor cortex neuron activity on noradrenergic and serotonergic transmission in unspecific thalamic nuclei. Neuroscience 1995;2:315-322.
36. Kia HK, Miquel MC, Brisorgueil MJ, et al. Immunocytochemical localization of serotonin 1A receptors in the rat central nervous system. J Comp Neurol 1996;365:289-305.
37. Sadzot B, Lemaire C, Maquet P, et al. Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [F-18]altanserin: results in young normal control subjects. J Cereb Blood Flow Metab 1995;15:787-797.
38. Gustafson EL, Durkin MM, Bard JA, Zgombick J, Branchek TA. A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-HT7 receptor in rat brain. Br J Pharmacol 1996;117:657-666.
39. Heils A, Teufel A, Petri S, et al. Allelic variation in the human serotonin transporter gene expression. J Neurochem 1996;66: 2621-2624.